Hem › Prostatacancer › Oklahoma › Oklahoma City
Kliniska studier för Prostatacancer i Oklahoma City, OK
21 studier för Prostatacancer söker deltagare vid platser i och runt Oklahoma City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekryterarFriska volontärer välkomna
- University of Oklahoma Health Sciences Center, Oklahoma City
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- University of Oklahoma, Oklahoma City
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RekryterarFas 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RekryterarFas 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Mercy Hospital Oklahoma City, Oklahoma City
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekryterarFas 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
RekryterarFas 3
- Oklahoma Proton Center, Oklahoma City
Protoacoustic Imaging For 3D Mapping
RekryterarObservationsstudie
- OU Health Stephenson Cancer Center, Oklahoma City
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
RekryterarFas 3
- Hightower Clinical, Oklahoma City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekryterarFas 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
RekryterarObservationsstudie
- OU Health Stephenson Cancer Center, Oklahoma City
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekryterarFas 3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
RekryterarFas 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekryterarFas 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
Rekryterar
- University of Oklahoma HSC, Oklahoma City
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
RekryterarFas 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RekryterarFas 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
RekryterarObservationsstudie
- OU Health Stephenson Cancer Center, Oklahoma City
Connect2Care: Prostate Cancer Education and Screenings for African American Men
Rekryterar
- TSET Health Promotion Research Center, Oklahoma City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekryterarFas 3
- University of Oklahoma Health Sciences Center, Oklahoma City
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #13, Oklahoma City
Prostatacancer-studier i andra städer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN43 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andra studier i Oklahoma City
- Icke-småcellig lungcancer28 studier
- Äggstockscancer28 studier
- Endometriecancer25 studier
- Kolorektal cancer22 studier
- Lungcancer19 studier
- Bröstcancer17 studier
- Metastaserande cancer16 studier
- Cancer (alla typer)14 studier
- Akut myeloid leukemi14 studier
- Plattenepitelcancer i huvud och hals13 studier
- Blåscancer11 studier
- Bukspottkörtelcancer11 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.